Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Global Health
Join Channel
Consolidated Standalone

Global Health

₹1111 -32.8 | 2.9%

Market Cap ₹29834 Cr.

Stock P/E 61.8

P/B 10.1

Current Price ₹1111

Book Value ₹ 109.5

Face Value 2

52W High ₹1513.8

Dividend Yield 0%

52W Low ₹ 675.3

Edit Ratio

Global Health Research see more...

Stocx User

Global Health Limited

Overview Inc. Year: 2004Industry: Hospital & Healthcare Services

Global Health Ltd is a healthcare technology company headquartered in Australia. The company provides software solutions to healthcare providers, hospitals, and government agencies to streamline and improve the delivery of healthcare services. Their flagship product, ReferralNet, is an electronic messaging platform that enables secure communication and sharing of patient information between healthcare professionals. The company's other products include a clinical and practice management software called MasterCare+, and a patient engagement platform called HotHealth. Global Health Ltd's solutions are used by healthcare providers in Australia, New Zealand, and Asia. The company is committed to using technology to improve healthcare outcomes and patient experiences.

Read More..

Global Health Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Global Health Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Global Health Profit & Loss

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Net Sales 1070 1194 1382 1277 1343 1441 1472 1227 1765 1974 2280
Other Income 34 36 45 67 49 65 44 28 35 48 103
Total Income 1103 1230 1427 1344 1392 1506 1516 1256 1800 2021 2383
Total Expenditure 851 931 1077 1151 1213 1297 1254 1054 1384 1552 1777
Operating Profit 252 300 350 193 179 208 262 201 416 470 606
Interest 0 9 14 23 28 21 33 29 33 32 30
Depreciation 47 62 69 81 86 91 99 88 87 86 87
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 205 229 268 90 64 97 131 84 296 352 489
Provision for Tax 72 79 92 35 27 34 28 27 77 88 128
Profit After Tax 133 150 176 55 37 63 103 57 219 263 361
Adjustments 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 133 150 176 55 37 63 103 57 219 263 361
Adjusted Earnings Per Share 5.7 6.3 7.3 2.3 1.5 2.6 4.2 2.3 8.6 9.8 13.4

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 16% 23% 10% 8%
Operating Profit CAGR 29% 44% 24% 9%
PAT CAGR 37% 85% 42% 11%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 60% NA% NA% NA%
ROE Average 14% 13% 10% 11%
ROCE Average 19% 19% 15% 16%

Global Health Balance Sheet

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Shareholder's Funds 731 886 1069 1151 1222 1312 1423 1484 1740 2489 2849
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 69 40 113 132 123 115 18 19 89 58 0
Other Non-Current Liabilities 96 78 76 108 95 82 306 647 723 811 958
Total Current Liabilities 228 214 238 272 269 249 260 268 302 397 420
Total Liabilities 1123 1218 1496 1664 1709 1758 2008 2418 2854 3754 4226
Fixed Assets 744 749 913 972 928 869 929 851 827 810 841
Other Non-Current Assets 65 59 75 66 317 429 643 1111 1311 1547 2095
Total Current Assets 315 410 508 625 463 460 436 455 716 1398 1291
Total Assets 1123 1218 1496 1664 1709 1758 2008 2418 2854 3754 4226

Global Health Cash Flow

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 56 61 61 37 43 41 40 132 45 65 643
Cash Flow from Operating Activities 252 214 228 124 80 152 193 201 235 431 341
Cash Flow from Investing Activities -65 -126 -245 -112 -46 -104 -45 -250 -313 -257 -699
Cash Flow from Financing Activities -181 -87 -7 -6 -36 -49 -56 -37 98 404 -66
Net Cash Inflow / Outflow 6 0 -24 6 -2 -1 92 -86 20 577 -424
Closing Cash & Cash Equivalent 61 61 37 43 41 40 132 45 65 643 219

Global Health Ratios

# Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Earnings Per Share (Rs) 5.66 6.27 7.28 2.27 1.54 2.56 4.16 2.31 8.64 9.82 13.44
CEPS(Rs) 7.65 8.86 10.13 5.6 5.1 6.25 8.16 5.85 12.08 13.03 16.68
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 29.64 35.59 42.49 44.39 45.99 49.9 54.38 57.23 68.49 92.61 105.94
Core EBITDA Margin(%) 20.4 22.04 22.07 9.91 9.66 9.97 14.84 14.09 21.58 21.38 22.08
EBIT Margin(%) 19.16 19.91 20.4 8.83 6.88 8.16 11.1 9.26 18.62 19.43 22.77
Pre Tax Margin(%) 19.16 19.17 19.36 7.02 4.77 6.7 8.89 6.88 16.76 17.82 21.43
PAT Margin (%) 12.47 12.52 12.71 4.31 2.78 4.37 6.98 4.67 12.4 13.34 15.83
Cash Profit Margin (%) 16.84 17.69 17.67 10.62 9.21 10.66 13.68 11.81 17.34 17.7 19.65
ROA(%) 11.99 12.77 12.94 3.48 2.21 3.63 5.46 2.59 8.3 7.97 9.04
ROE(%) 21.13 19.33 18.76 5.24 3.41 5.38 8 4.15 13.88 12.48 13.55
ROCE(%) 23.62 26.53 26.39 8.89 6.78 8.29 11.3 7.69 19.51 17.23 18.88
Receivable days 14.69 13.94 16.98 26.04 35.14 40.02 38.75 41.37 31.32 32.01 29.21
Inventory Days 6.82 6.96 6.99 7.02 6 5.83 6.89 9.51 7.41 7.6 6.92
Payable days 0 93.89 87.88 125.81 122.55 130.54 142.14 139.28 87.93 97.72 94.61
PER(x) 0 0 0 0 0 0 0 0 0 53.6 98.48
Price/Book(x) 0 0 0 0 0 0 0 0 0 5.68 12.5
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) -0.03 -0.15 -0.11 -0.16 -0 -0.02 -0.08 -0.12 -0.15 6.62 15.19
EV/Core EBITDA(x) -0.11 -0.58 -0.45 -1.06 -0.02 -0.11 -0.43 -0.74 -0.65 27.83 57.14
Net Sales Growth(%) 16.68 11.62 15.73 -7.58 5.17 7.29 2.15 -16.62 43.8 11.82 15.53
EBIT Growth(%) 34.28 16.01 18.54 -60 -18.08 27.39 38.94 -30.49 189.25 16.69 35.36
PAT Growth(%) 29.3 12.1 17.47 -68.67 -32.14 68.58 63.27 -44.25 281.92 20.32 37.09
EPS Growth(%) 27.79 10.81 16.13 -68.85 -32.14 66.39 62.56 -44.52 273.93 13.61 36.93
Debt/Equity(x) 0.17 0.05 0.13 0.16 0.15 0.11 0.02 0.02 0.07 0.04 0.02
Current Ratio(x) 1.38 1.92 2.13 2.3 1.72 1.85 1.67 1.7 2.37 3.52 3.08
Quick Ratio(x) 1.29 1.8 2.02 2.22 1.64 1.75 1.55 1.58 2.24 3.42 2.97
Interest Cover(x) 0 26.67 19.72 4.9 3.27 5.57 5.02 3.89 10.01 12.05 17.04
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0.01 0

Global Health Shareholding Pattern

# Aug 2018 Mar 2019 Mar 2020 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
Promoter 49.27 48.63 48.42 33.08 33.08 33.07 33.06 33.05 33.04 33.04
FII 0 0 0 9.35 9.89 10.58 10.69 11.36 12.09 12.94
DII 0 0 0 12.55 12.35 10.8 10.93 11.15 10.25 10.57
Public 50.73 51.37 51.58 45.02 44.68 45.55 45.33 44.44 44.61 43.44
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 41% CAGR over last 5 years
  • Debtor days have improved from 97.72 to 94.61days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 33.04%.
  • Company has a low return on equity of 13% over the last 3 years.
  • Stock is trading at 10.1 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Global Health News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!